Page last updated: 2024-12-07

12-deoxyphorbolphenylacetate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

12-deoxyphorbolphenylacetate (also known as 12-deoxyphorbol-13-phenylacetate, or abbreviated as DPPA) is a **synthetic analog of phorbol esters**, which are compounds found in the latex of the croton plant (Croton tiglium).

**Importance for research:**

DPPA is a **potent activator of protein kinase C (PKC)**, a family of enzymes that play a crucial role in various cellular processes, including:

* **Cell growth and proliferation:** PKC activation can lead to the expression of genes involved in cell division and growth.
* **Cell differentiation:** PKC is involved in the regulation of cell fate decisions and can promote differentiation into specific cell types.
* **Inflammation:** PKC activation contributes to inflammatory responses by promoting the production of inflammatory mediators.
* **Neurotransmission:** PKC is involved in the regulation of synaptic plasticity and neuronal signaling.

**Specific applications in research:**

* **Investigating PKC signaling pathways:** DPPA is used as a tool to study the role of PKC in various cellular processes.
* **Developing new cancer treatments:** Since PKC activation can promote cell growth, DPPA can be used to investigate potential targets for cancer therapy.
* **Studying inflammation:** DPPA can be used to model inflammatory responses and investigate potential anti-inflammatory agents.
* **Neuroscience research:** DPPA is used to study the role of PKC in neuronal signaling and synaptic plasticity.

**Important notes:**

* DPPA is a **highly potent compound** and should be handled with caution.
* Its use in research requires careful consideration of potential **toxicity** and **off-target effects**.

**In summary,** 12-deoxyphorbolphenylacetate is a valuable research tool that helps scientists understand the role of protein kinase C in various cellular processes and explore its potential applications in different fields of research, including cancer, inflammation, and neuroscience.

12-deoxyphorbolphenylacetate: RN given refers to (1aR-(1aalpha,1bbeta,4abeta,7aalpha,7balpha,8alpha,9aalpha))-isomer [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID105100
SCHEMBL ID22722450
MeSH IDM0094573

Synonyms (12)

Synonym
5h-cyclopropa(3,4)benz(1,2-e)azulen-5-one, 1,1a-alpha,1b-beta,4,4a,7a-alpha,7b,8,9,9a-decahydro-4a-beta,7b-alpha,9a-alpha-trihydroxy-3-(hydroxymethyl)-1,1,6,8-alpha-tetramethyl-, 9a-phenylacetate
12-deoxyphorbol-13-phenylacetate
12-deoxyphorbol 13-phenylacetate
ccris 6293
brn 1898359
benzeneacetic acid, (1ar,1bs,4ar,7as,7br,8r,9as)-1,1a,1b,4,4a,5,7a,7b,8,9-decahydro-4a,7b-dihydroxy-3-(hydroxymethyl)-1,1,6,8-tetramethyl-5-oxo-9ah-cyclopropa(3,4)benz(1,2-e)azulen-9a-yl ester
12-deoxyphorbolphenylacetate
58821-98-0
[(1r,2s,6r,10s,13s,15r)-1,6-dihydroxy-8-(hydroxymethyl)-4,12,12,15-tetramethyl-5-oxo-13-tetracyclo[8.5.0.02,6.011,13]pentadeca-3,8-dienyl] 2-phenylacetate
4a,7b-dihydroxy-3-(hydroxymethyl)-1,1,6,8-tetramethyl-5-oxo-1,1a,1b,4,4a,5,7a,7b,8,9-decahydro-9ah-cyclopropa[3,4]benzo[1,2-e]azulen-9a-yl phenylacetate
DTXSID00974338
SCHEMBL22722450

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" A similar dose-response effect was seen with sapintoxin D (SAP D), the stage 2 promoting analogue of 12-O-tetradecanoylphorbol-13-acetate and the complete promoter phorbol 12,13-dibutyrate (PDB)."( Both tumour-promoting and non-promoting phorbol esters inhibit [125I]EGF binding and stimulate the phosphorylation of an 80 kd protein kinase C substrate protein in intact quiescent swiss 3T3 cells.
Brooks, G; Brooks, SF, 1990
)
0.28
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (35)

TimeframeStudies, This Drug (%)All Drugs %
pre-19905 (14.29)18.7374
1990's25 (71.43)18.2507
2000's3 (8.57)29.6817
2010's2 (5.71)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.22

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.22 (24.57)
Research Supply Index3.58 (2.92)
Research Growth Index4.80 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.22)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other35 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]